Innovating Works

IDP2Biomed

Financiado
Bringing Intrinsically Disordered Proteins to Biomedical Applications
The IDP2Biomed twinning program is aimed at strengthening the scientific excellence and innovation capacity at the interface between Chemistry and Biology of the Faculty of Science of Eötvös Loránd University (ELTE). Researchers f... The IDP2Biomed twinning program is aimed at strengthening the scientific excellence and innovation capacity at the interface between Chemistry and Biology of the Faculty of Science of Eötvös Loránd University (ELTE). Researchers from ELTE will be working closely together with three leading European research groups in the field of intrinsically disordered proteins (IDPs). This partnership will provide an ideal platform to enable ELTE to increase its ability to generate scientific innovation and clinical translation. This objective will be achieved by focusing on IDPs that are directly involved in diseases with great socio-economic importance, such as neurodegenerative diseases and rare diseases. IDP2Biomed will integrate IDP-related information with biomedical data, advance the understanding of the function of IDPs in normal and disease states and explore new avenues to alter their behaviour in pathological states. The impact of this program will be maximised by fostering cooperation with academic and industrial partners locally and across the EU. ver más
30/09/2027
ELTE
1M€
Duración del proyecto: 40 meses Fecha Inicio: 2024-05-09
Fecha Fin: 2027-09-30

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-09
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
HORIZON-WIDERA-2023-ACCESS-02-01: Twinning Bottom-Up
Cerrada hace 1 año
Presupuesto El presupuesto total del proyecto asciende a 1M€
Líder del proyecto
EOTVOS LORAND TUDOMANYEGYETEM No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5